Deciphering adaptor specificity in GFL-dependent RET-mediated proliferation and neurite outgrowth

Journal of Neurochemistry

Volumn 102, Issue 4, 2007, Pages 1184-1194

  Gustin, Jason A ^a   Yang, Mao ^a   Johnson Jr , Eugene M ^a   Milbrandt, Jeffrey ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Growth factor receptor binding protein 2; Lentivirus; Proliferation; RET; Small interfering RNA; Src homology 2

Indexed keywords

ADAPTOR PROTEIN; BINDING PROTEIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR BINDING PROTEIN 2; LENTIVIRUS VECTOR; PROTEIN TYROSINE KINASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL SPECIFICITY; CELL STIMULATION; CONTROLLED STUDY; MOUSE; NERVE CELL GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; SRC HOMOLOGY DOMAIN; WILD TYPE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CELL LINE, TRANSFORMED; CELL MOVEMENT; CELL PROLIFERATION; ENZYME ACTIVATION; FIBROBLASTS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GRB2 ADAPTOR PROTEIN; MUTATION; NEURITES; PC12 CELLS; PROTO-ONCOGENE PROTEINS C-RET; RATS; RNA, SMALL INTERFERING; TYROSINE;

LENTIVIRUS;

EID: 34547490707     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04624.x     Document Type: Article

References (69)

1. Arighi E., Alberti L., Torriti F. et al. (1997) Identification of Shc docking site on Ret tyrosine kinase. Oncogene 14, 773 782.
2. Arighi E., Popsueva A., Degl'Innocenti D., Borrello M. G., Carniti C., Perala N. M., Pierotti M. A. Sariola H. (2004) Biological effects of the dual phenotypic Janus mutation of ret cosegregating with both multiple endocrine neoplasia type 2 and Hirschsprung's disease. Mol. Endocrinol. 18, 1004 1017.
3. Arighi E., Borrello M. G. Sariola H. (2005) RET tyrosine kinase signaling in development and cancer. Cytokine Growth Factor Rev. 16, 441 467.
4. Asai N., Iwashita T., Matsuyama M. Takahashi M. (1995) Mechanism of activation of the ret proto-oncogene by multiple endocrine neoplasia 2A mutations. Mol. Cell. Biol. 15, 1613 1619.
5. Asai N., Murakami H., Iwashita T. Takahashi M. (1996) A mutation at tyrosine 1062 in MEN2A-Ret and MEN2B-Ret impairs their transforming activity and association with shc adaptor proteins. J. Biol. Chem. 271, 17644 17649.
6. Baloh R. H., Enomoto H., Johnson E. M. Jr. Milbrandt J. (2000) The GDNF family ligands and receptors - implications for neural development. Curr. Opin. Neurobiol. 10, 103 110.
7. Bongarzone I., Vigano E., Alberti L. et al. (1998) Full activation of MEN2B mutant RET by an additional MEN2A mutation or by ligand GDNF stimulation. Oncogene 16, 2295 2301.
8. Borrello M. G., Pelicci G., Arighi E., De Filippis L., Greco A., Bongarzone I., Rizzetti M., Pelicci P. G. Pierotti M. A. (1994) The oncogenic versions of the Ret and Trk tyrosine kinases bind Shc and Grb2 adaptor proteins. Oncogene 9, 1661 1668.
9. Borrello M. G., Alberti L., Arighi E. et al. (1996) The full oncogenic activity of Ret/ptc2 depends on tyrosine 539, a docking site for phospholipase C gamma. Mol. Cell. Biol. 16, 2151 2163.
10. Carlomagno F., Melillo R. M., Visconti R. et al. (1998) Glial cell line-derived neurotrophic factor differentially stimulates ret mutants associated with the multiple endocrine neoplasia type 2 syndromes and Hirschsprung's disease. Endocrinology 139, 3613 3619.
11. Chen L. Carter-Su C. (2004) Adapter protein SH2-B beta undergoes nucleocytoplasmic shuttling: implications for nerve growth factor induction of neuronal differentiation. Mol Cell Biol. 24, 3633 3647.
12. Chen B., Nelson D. M. Sadovsky Y. (2006) N-myc down-regulated gene 1 modulates the response of term human trophoblasts to hypoxic injury. J. Biol. Chem. 281, 2764 2772.
13. Coulpier M., Anders J. Ibanez C. F. (2002) Coordinated activation of autophosphorylation sites in the RET receptor tyrosine kinase: importance of tyrosine 1062 for GDNF mediated neuronal differentiation and survival. J. Biol. Chem. 277, 1991 1999.
14. Creedon D. J., Tansey M. G., Baloh R. H., Osborne P. A., Lampe P. A., Fahrner T. J., Heuckeroth R. O., Milbrandt J. Johnson E. M. Jr. (1997) Neurturin shares receptors and signal transduction pathways with glial cell line-derived neurotrophic factor in sympathetic neurons. Proc. Natl Acad. Sci. USA 94, 7018 7023.
15. Crowder R. J., Enomoto H., Yang M., Johnson E. M. Jr. Milbrandt J. (2004) Dok-6, a Novel p62 Dok family member, promotes Ret-mediated neurite outgrowth. J. Biol. Chem. 279, 42072 42081.
16. Degl'Innocenti D., Arighi E., Popsueva A., Sangregorio R., Alberti L., Rizzetti M. G., Ferrario C., Sariola H., Pierotti M. A. Borrello M. G. (2004) Differential requirement of Tyr1062 multidocking site by RET isoforms to promote neural cell scattering and epithelial cell branching. Oncogene 23, 7297 7309.
17. Encinas M., Tansey M. G., Tsui-Pierchala B. A., Comella J. X., Milbrandt J. Johnson E. M. Jr. (2001) c-Src is required for glial cell line-derived neurotrophic factor (GDNF) family ligand-mediated neuronal survival via a phosphatidylinositol-3 kinase (PI-3 K)-dependent pathway. J. Neurosci. 21, 1464 1472.
18. Encinas M., Crowder R. J., Milbrandt J. Johnson E. M. Jr. (2004) Tyrosine 981, a novel ret autophosphorylation site, binds c-Src to mediate neuronal survival. J. Biol. Chem. 279, 18262 18269.
19. Eng C., Smith D. P., Mulligan L. M. et al. (1994) Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum. Mol. Genet. 3, 237 241.
20. Enomoto H., Crawford P. A., Gorodinsky A., Heuckeroth R. O., Johnson E. M. Jr. Milbrandt J. (2001) RET signaling is essential for migration, axonal growth and axon guidance of developing sympathetic neurons. Development 128, 3963 3974.
21. Fukuda M., Gotoh Y., Tachibana T., Dell K., Hattori S., Yoneda Y. Nishida E. (1995) Induction of neurite outgrowth by MAP kinase in PC12 cells. Oncogene 11, 239 244.
22. Funahashi H., Okada Y., Sawai H., Takahashi H., Matsuo Y., Takeyama H. Manabe T. (2005) The role of glial cell line-derived neurotrophic factor (GDNF) and integrins for invasion and metastasis in human pancreatic cancer cells. J. Surg. Oncol. 91, 77 83.
23. van der Geer P., Wiley S., Gish G. D. Pawson T. (1996) The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions. Curr. Biol. 6, 1435 1444.
24. Glass D. J., Nye S. H., Hantzopoulos P., Macchi M. J., Squinto S. P., Goldfarb M. Yancopoulos G. D. (1991) TrkB mediates BDNF/NT-3-dependent survival and proliferation in fibroblasts lacking the low affinity NGF receptor. Cell 66, 405 413.
25. Grimm J., Sachs M., Britsch S., Di Cesare S., Schwarz-Romond T., Alitalo K. Birchmeier W. (2001) Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation. J. Cell Biol. 154, 345 354.
26. Gu H., Maeda H., Moon J. J., Lord J. D., Yoakim M., Nelson B. H. Neel B. G. (2000) New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway. Mol. Cell. Biol. 20, 7109 7120.
27. Hartmann G., Prospero T., Brinkmann V. et al. (1998) Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo. Curr. Biol. 8, 125 134.
28. Hayashi H., Ichihara M., Iwashita T. et al. (2000) Characterization of intracellular signals via tyrosine 1062 in RET activated by glial cell line-derived neurotrophic factor. Oncogene 19, 4469 4475.
29. Ishiguro Y., Iwashita T., Murakami H., Asai N., Iida K., Goto H., Hayakawa T. Takahashi M. (1999) The role of amino acids surrounding tyrosine 1062 in ret in specific binding of the shc phosphotyrosine-binding domain. Endocrinology 140, 3992 3998.
30. Iwashita T., Asai N., Murakami H., Matsuyama M. Takahashi M. (1996) Identification of tyrosine residues that are essential for transforming activity of the ret proto-oncogene with MEN2A or MEN2B mutation. Oncogene 12, 481 487.
31. Iwashita T., Kato M., Murakami H. et al. (1999) Biological and biochemical properties of Ret with kinase domain mutations identified in multiple endocrine neoplasia type 2B and familial medullary thyroid carcinoma. Oncogene 18, 3919 3922.
32. Jain S., Naughton C. K., Yang M. et al. (2004) Mice expressing a dominant-negative Ret mutation phenocopy human Hirschsprung disease and delineate a direct role of Ret in spermatogenesis. Development 131, 5503 5513.
33. Jain S., Encinas M., Johnson E. M. Jr. Milbrandt J. (2006) Critical and distinct roles for key RET tyrosine docking sites in renal development. Genes Dev. 20, 321 333.
34. Jijiwa M., Fukuda T., Kawai K., Nakamura A., Kurokawa K., Murakumo Y., Ichihara M. Takahashi M. (2004) A targeting mutation of tyrosine 1062 in Ret causes a marked decrease of enteric neurons and renal hypoplasia. Mol. Cell. Biol. 24, 8026 8036.
35. Kurokawa K., Iwashita T., Murakami H., Hayashi H., Kawai K. Takahashi M. (2001) Identification of SNT/FRS2 docking site on RET receptor tyrosine kinase and its role for signal transduction. Oncogene 20, 1929 1938.
36. Liu X., Vega Q. C., Decker R. A., Pandey A., Worby C. A. Dixon J. E. (1996) Oncogenic RET receptors display different autophosphorylation sites and substrate binding specificities. J. Biol. Chem. 271, 5309 5312.
37. Lois C., Hong E. J., Pease S., Brown E. J. Baltimore D. (2002) Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295, 868 872.
38. Lorenzo M. J., Gish G. D., Houghton C., Stonehouse T. J., Pawson T., Ponder B. A. Smith D. P. (1997) RET alternate splicing influences the interaction of activated RET with the SH2 and PTB domains of Shc, and the SH2 domain of Grb2. Oncogene 14, 763 771.
39. Lundgren T. K., Scott R. P., Smith M., Pawson T. Ernfors P. (2006) Engineering the recruitment of phosphotyrosine binding domain-containing adaptor proteins reveals distinct roles for RET receptor-mediated cell survival. J. Biol. Chem. 281, 29886 29896.
40. Luo Y., Ceccherini I., Pasini B. et al. (1993) Close linkage with the RET protooncogene and boundaries of deletion mutations in autosomal dominant Hirschsprung disease. Hum. Mol. Genet. 2, 1803 1808.
41. Madhani H. D. (2001) Accounting for specificity in receptor tyrosine kinase signaling. Cell 106, 9 11.
42. Meakin S. O., MacDonald J. I., Gryz E. A., Kubu C. J. Verdi J. M. (1999) The signaling adapter FRS-2 competes with Shc for binding to the nerve growth factor receptor TrkA. A model for discriminating proliferation and differentiation. J. Biol. Chem. 274, 9861 9870.
43. Melillo R. M., Carlomagno F., De Vita G., Formisano P., Vecchio G., Fusco A., Billaud M. Santoro M. (2001a) The insulin receptor substrate (IRS)-1 recruits phosphatidylinositol 3-kinase to Ret: evidence for a competition between Shc and IRS-1 for the binding to Ret. Oncogene 20, 209 218.
44. Melillo R. M., Santoro M., Ong S. H., Billaud M., Fusco A., Hadari Y. R., Schlessinger J. Lax I. (2001b) Docking protein FRS2 links the protein tyrosine kinase RET and its oncogenic forms with the mitogen-activated protein kinase signaling cascade. Mol. Cell. Biol. 21, 4177 4187.
45. Meng X., Lindahl M., Hyvonen M. E. et al. (2000) Regulation of cell fate decision of undifferentiated spermatogonia by GDNF. Science 287, 1489 1493.
46. Mulligan L. M., Kwok J. B., Healey C. S. et al. (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363, 458 460.
47. Nagai T., Ibata K., Park E. S., Kubota M., Mikoshiba K. Miyawaki A. (2002) A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat. Biotechnol. 20, 87 90.
48. Naughton C. K., Jain S., Strickland A. M., Gupta A. Milbrandt J. (2006) Glial cell-line derived neurotrophic factor-mediated RET signaling regulates spermatogonial stem cell fate. Biol. Reprod. 74, 314 321.
49. Pachnis V., Mankoo B. Costantini F. (1993) Expression of the c-ret proto-oncogene during mouse embryogenesis. Development 119, 1005 1017.
50. Pages G., Lenormand P., L'Allemain G., Chambard J. C., Meloche S. Pouyssegur J. (1993) Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc. Natl Acad. Sci. USA 90, 8319 8323.
51. Pandey A., Duan H., Di Fiore P. P. Dixit V. M. (1995) The Ret receptor protein tyrosine kinase associates with the SH2-containing adapter protein Grb10. J. Biol. Chem. 270, 21461 21463.
52. Pasini B., Borrello M. G., Greco A. et al. (1995) Loss of function effect of RET mutations causing Hirschsprung disease. Nat. Genet. 10, 35 40.
53. Pelicci G., Lanfrancone L., Grignani F., McGlade J., Cavallo F., Forni G., Nicoletti I., Grignani F., Pawson T. Pelicci P. G. (1992) A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70, 93 104.
54. Pelicci G., Troglio F., Bodini A., Melillo R. M., Pettirossi V., Coda L., De Giuseppe A., Santoro M. Pelicci P. G. (2002) The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathway. Mol. Cell. Biol. 22, 7351 7363.
55. Reynolds A., Leake D., Boese Q., Scaringe S., Marshall W. S. Khvorova A. (2004) Rational siRNA design for RNA interference. Nat. Biotechnol. 22, 326 330.
56. Robertson S. C., Tynan J. A. Donoghue D. J. (2000) RTK mutations and human syndromeswhen good receptors turn bad. Trends Genet. 16, 265 271.
57. Rossig L., Jadidi A. S., Urbich C., Badorff C., Zeiher A. M. Dimmeler S. (2001) Akt-dependent phosphorylation of p21(Cip1) regulates PCNA binding and proliferation of endothelial cells. Mol. Cell. Biol. 21, 5644 5657.
58. Rozakis-Adcock M., Fernley R., Wade J., Pawson T. Bowtell D. (1993) The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature 363, 83 85.
59. Santoro M., Carlomagno F., Romano A. et al. (1995) Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 267, 381 383.
60. Schuchardt A., D'Agati V., Larsson-Blomberg L., Costantini F. Pachnis V. (1994) Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 367, 380 383.
61. Segouffin-Cariou C. Billaud M. (2000) Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway. J. Biol. Chem. 275, 3568 3576.
62. Skolnik E. Y., Lee C. H., Batzer A. et al. (1993) The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. EMBO J. 12, 1929 1936.
63. Smith D. P., Eng C. Ponder B. A. (1994) Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes and Hirschsprung disease. J. Cell Sci. Suppl. 18, 43 49.
64. Tsui-Pierchala B. A., Ahrens R. C., Crowder R. J., Milbrandt J. Johnson E. M. Jr. (2002) The long and short isoforms of Ret function as independent signaling complexes. J. Biol. Chem. 277, 34618 34625.
65. Veit C., Genze F., Menke A., Hoeffert S., Gress T. M., Gierschik P. Giehl K. (2004) Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells. Cancer Res. 64, 5291 5300.
66. Wang L. M., Zhang Q., Zhang Q., Zhu W., He C., Lu C. L., Ding D. F. Chen Z. Y. (2004) Identification of the key amino acids of glial cell line-derived neurotrophic factor family receptor alpha1 involved in its biological function. J. Biol. Chem. 279, 109 116.
67. Wong A., Bogni S., Kotka P., de Graaff E., D'Agati V., Costantini F. Pachnis V. (2005) Phosphotyrosine 1062 is critical for the in vivo activity of the Ret9 receptor tyrosine kinase isoform. Mol. Cell. Biol. 25, 9661 9673.
68. Worby C. A., Vega Q. C., Zhao Y., Chao H. H., Seasholtz A. F. Dixon J. E. (1996) Glial cell line-derived neurotrophic factor signals through the RET receptor and activates mitogen-activated protein kinase. J. Biol. Chem. 271, 23619 23622.
69. Yu W. H., Woessner J. F. Jr., McNeish J. D. Stamenkovic I. (2002) CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling. Genes Dev. 16, 307 323.